The Research Award recognises once every two years a spanish author who has published what is considered by the international jury to be the best article related to pharmacotherapy in any scientific journal in the world.
Dr.Antonio Esteve Foundation
TORRE ESTEVEPasseig de la Zona Franca, 109
08038 Barcelona
Tel:
93 433 53 20
E-mail:
fundacion@esteve.org
The Research Award recognises once every two years a spanish author who has published what is considered by the international jury to be the best article related to pharmacotherapy in any scientific journal in the world.
This prize, offered biennially by the Esteve Foundation to the best work on pharmacological research, was awarded this year to the study Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2, published in the British Journal of Pharmacology (volume 126, pages 301-311) in 1999.
The sixth Esteve Foundation Research Prize to the best work on pharmacological research was awarded this year to the study Choline Kinase inhibitors as a novel approach for antiproliferative drug design, published in Oncogene in 1997. The contribution of these scientists from the Biomedical Research Institute of the CSIC was an important step in the…
Eight doctors of the Service of Immunology of the Hospital La Princesa of Madrid were awarded the fifth Esteve Foundation Research Prize for their workPrevention of in vitro neutrophil-endothelial attachment through shedding of L-selection by nonsteroidal antiinflammatory drugs, published in the Journal of Clinical Investigation in 1995 (J. Clin. Invest. 95:1756-1765).
The Esteve Foundation awarded its fourth Research Price ex-aequo to the following studies: Effect of adenosine A1 and A2 agonists and antagonists on cAMP and Ca2+ in cultured rat mesangial cells (Am. J. Physiol. 262:C840-844,1992), and Long term treatment with desipramine increases the turnover of alpha2-adrenoceptors in the rat brain (Mol. Pharmacol. 42:846-855,1992).
The Esteve Foundation awarded its fourth Research Price ex-aequo to the following studies: Effect of adenosine A1 and A2 agonists and antagonists on cAMP and Ca2+ in cultured rat mesangial cells (Am. J. Physiol. 262:C840-844,1992), and Long term treatment with desipramine increases the turnover of alpha2-adrenoceptors in the rat brain (Mol. Pharmacol. 42:846-855,1992).
The study Activation of facilitation calcium channels in chromaffin cells by D1 dopamine receptors through a cAMP/protein kinase A-dependent mechanism, published by Nature in 1990 (348:239-242) was awarded the third Esteve Foundation Research Price. The jury considered that this was a fundamental contribution to the study of the relationships between calcium channels and neurotransmitters. The jury…
The second Esteve Foundation Research Prize was awarded to the study Tolerance to respiratory actions of sufentanil: functional tolerance and route-dependent differential tolerance, published in the Journal of Pharmacology and Experimental Therapeutics in 1989 (250:371-378). The jury considered that this was a fundamental contribution to the knowledge of the mechanisms of narcotic dependence. The elucidation…
In the year 1989, the Esteve Foundation started a new activity: Research Prizes would be awarded biennially to the best work on pharmacological research performed by Spanish authors and published in a scientific journal. The jury of this first call decided to award the prize to the Department of Pharmacology of the Faculty of Medicine…